De Waele, Laure; Sakai, Kazuya; Mancini, Ilaria; Sinkovits, György; Falter, Tanja; Inoue, Takashi; Agosti, Pasquale; Rossmann, Heidi; Von Auer, Charis; Tersteeg, Claudia; De Meyer, Simon F; Joly, Bérangère S; Veyradier, Agnès; Coppo, Paul; Fijnheer, Rob; Peyvandi, Flora; Prohászka, Zoltán; Lämmle, Bernhard; Vanhoorelbeke, Karen (2024). Open ADAMTS13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 22(2), pp. 493-502. Wiley-Blackwell 10.1016/j.jtha.2023.10.014
Text
1-s2.0-S1538783623007833-main.pdf - Accepted Version Restricted to registered users only until 20 October 2024. Available under License Publisher holds Copyright. Download (1MB) |
BACKGROUND
ADAMTS13 adopts an open conformation in immune-mediated thrombotic thrombocytopenic purpura (iTTP) patients in acute phase while being closed in healthy donors. We reported that a substantial number of iTTP patients in remission with restored ADAMTS13 activity (>50%) still had an open ADAMTS13 conformation, although a closed conformation is expected given the extent of remission.
OBJECTIVE
To investigate whether open ADAMTS13, represented by conformation index >0.5, is associated with a risk for earlier ADAMTS13 and/or clinical relapse.
PATIENTS/METHODS
We collected follow-up data (ADAMTS13 parameters, ADAMTS13 and clinical relapse and treatment) from 81 iTTP patients in remission with ADAMTS13 activity above 50%.
RESULTS
During follow-up, 19 ADAMTS13 and 10 clinical relapses were reported (median follow up period: 20 months). First, open or closed ADAMTS13 conformation was dichotomized based on the 0.5 conformation index cut-off. Open ADAMTS13 (conformation index >0.5) was not identified as a risk for ADAMTS13 and clinical relapse (log-rank test and Cox regression model). In contrast, by identifying the optimal conformation index cut-off for relapse prediction, using classification and regression tree analysis, conformation index >0.645 and >0.835 were shown to be a risk for respectively ADAMTS13 relapse (hazard ratio (HR) 3.3, (95% CI:1.3-8.3), p=0.01) and clinical relapse (HR 4.4, (95% CI:1.3-15.3), p=0.02).
CONCLUSION
Patients with open ADAMTS13 with conformation index >0.645 and >0.835, respectively have an over 3- and 4-fold higher risk for earlier ADAMTS13 and clinical relapse. Hence, ADAMTS13 conformation index could be used to complement ADAMTS13 activity monitoring to timely notice ADAMTS13 relapse and prevent clinical relapse.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory |
UniBE Contributor: |
Lämmle, Bernhard |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1538-7836 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
23 Oct 2023 11:03 |
Last Modified: |
05 Feb 2024 00:13 |
Publisher DOI: |
10.1016/j.jtha.2023.10.014 |
PubMed ID: |
37866519 |
Uncontrolled Keywords: |
ADAMTS13 activity ADAMTS13 conformation Autoantibodies Relapse Thrombotic thrombocytopenic purpura |
BORIS DOI: |
10.48350/187367 |
URI: |
https://boris.unibe.ch/id/eprint/187367 |